Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold.

Fagerholm P, Lagali NS, Ong JA, Merrett K, Jackson WB, Polarek JW, Suuronen EJ, Liu Y, Brunette I, Griffith M.

Biomaterials. 2014 Mar;35(8):2420-7. doi: 10.1016/j.biomaterials.2013.11.079. Epub 2013 Dec 25.

2.

A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study.

Fagerholm P, Lagali NS, Merrett K, Jackson WB, Munger R, Liu Y, Polarek JW, Söderqvist M, Griffith M.

Sci Transl Med. 2010 Aug 25;2(46):46ra61. doi: 10.1126/scitranslmed.3001022.

3.

Recombinant microbial systems for the production of human collagen and gelatin.

Báez J, Olsen D, Polarek JW.

Appl Microbiol Biotechnol. 2005 Dec;69(3):245-52. Epub 2005 Nov 15. Review.

PMID:
16240115
4.

Expression and characterization of a low molecular weight recombinant human gelatin: development of a substitute for animal-derived gelatin with superior features.

Olsen D, Jiang J, Chang R, Duffy R, Sakaguchi M, Leigh S, Lundgard R, Ju J, Buschman F, Truong-Le V, Pham B, Polarek JW.

Protein Expr Purif. 2005 Apr;40(2):346-57.

PMID:
15766877
5.

The application of recombinant human collagen in tissue engineering.

Yang C, Hillas PJ, Báez JA, Nokelainen M, Balan J, Tang J, Spiro R, Polarek JW.

BioDrugs. 2004;18(2):103-19. Review.

PMID:
15046526
6.

Characterization of a hyaluronic acid-Arg-Gly-Asp peptide cell attachment matrix.

Glass JR, Dickerson KT, Stecker K, Polarek JW.

Biomaterials. 1996 Jun;17(11):1101-8.

PMID:
8718970
7.

Effects of an arginine-glycine-aspartic acid peptide-containing artificial matrix on epithelial migration in vitro and experimental second-degree burn wound healing in vivo.

Mertz PM, Davis SC, Franzen L, Uchima FD, Pickett MP, Pierschbacher MD, Polarek JW.

J Burn Care Rehabil. 1996 May-Jun;17(3):199-206.

PMID:
8736364
8.
9.

Manipulation of cellular interactions with biomaterials toward a therapeutic outcome: a perspective.

Pierschbacher MD, Polarek JW, Craig WS, Tschopp JF, Sipes NJ, Harper JR.

J Cell Biochem. 1994 Oct;56(2):150-4. Review.

PMID:
7829572
10.

KdpD and KdpE, proteins that control expression of the kdpABC operon, are members of the two-component sensor-effector class of regulators.

Walderhaug MO, Polarek JW, Voelkner P, Daniel JM, Hesse JE, Altendorf K, Epstein W.

J Bacteriol. 1992 Apr;174(7):2152-9.

11.
12.

The bacterial Kdp K(+)-ATPase and its relation to other transport ATPases, such as the Na+/K(+)- and Ca2(+)-ATPases in higher organisms.

Epstein W, Walderhaug MO, Polarek JW, Hesse JE, Dorus E, Daniel JM.

Philos Trans R Soc Lond B Biol Sci. 1990 Jan 30;326(1236):479-86; discussion 486-7. Review.

PMID:
1970651
13.

Genetics of Kdp, the K+-transport ATPase of Escherichia coli.

Polarek JW, Walderhaug MO, Epstein W.

Methods Enzymol. 1988;157:655-67. No abstract available.

PMID:
2976470
14.

Resident research award. Effects of cholecystokinin on gallbladder stasis and cholesterol gallstone formation.

Roslyn JJ, DenBesten L, Pitt HA, Kuchenbecker S, Polarek JW.

J Surg Res. 1981 Mar;30(3):200-4. No abstract available.

PMID:
7230765
15.

The differing effects of early and chronic cholelithiasis on hepatic bile lithogenicity.

Roslyn JJ, Kuchenbecker S, DenBesten L, Pitt HA, Polarek JW.

Am J Surg. 1981 Jan;141(1):34-9.

PMID:
7457725

Supplemental Content

Loading ...
Support Center